Archives of Cardiovascular Diseases
Scope & Guideline
Elevating knowledge in cardiovascular diseases for better outcomes.
Introduction
Aims and Scopes
- Clinical Cardiology and Management:
Focused on the diagnosis, treatment, and management of cardiovascular diseases, including acute and chronic conditions such as coronary artery disease, heart failure, and arrhythmias. - Cardiovascular Imaging and Diagnostics:
Dedicated to advancements in imaging techniques and diagnostic methodologies, including echocardiography, cardiac magnetic resonance imaging, and novel biomarker assessments. - Interventional Cardiology:
Covers research related to catheter-based interventions, transcatheter aortic valve implantation (TAVI), and other minimally invasive procedures for treating cardiovascular diseases. - Cardiovascular Pharmacotherapy:
Explores the use of pharmacological agents in managing cardiovascular conditions, including the efficacy and safety of new drugs and treatment regimens. - Epidemiology and Public Health:
Investigates the epidemiological trends, risk factors, and public health implications of cardiovascular diseases, contributing to a better understanding of disease prevention and management strategies. - Innovative Therapies and Technologies:
Focuses on the development and evaluation of innovative therapies, including gene therapy, stem cell treatments, and emerging technologies in cardiovascular care.
Trending and Emerging
- Remote Monitoring and Telemedicine:
With the rise of digital health technologies, there is an increasing focus on remote monitoring of patients with cardiovascular diseases, particularly in the context of managing chronic conditions and during the COVID-19 pandemic. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in predicting cardiovascular events and outcomes is gaining prominence, showcasing the integration of advanced analytics in clinical cardiology. - Personalized and Precision Medicine:
Emerging research is emphasizing personalized treatment approaches based on genetic, biomarker, and patient-specific data, aimed at optimizing therapeutic outcomes in cardiovascular care. - Cardiovascular Outcomes in Cancer Patients:
Research investigating the intersection between cardiovascular health and cancer management is becoming increasingly relevant, particularly as survival rates improve and long-term cardiovascular risks are recognized. - Heart Failure with Preserved Ejection Fraction (HFpEF):
The focus on HFpEF is growing, with studies exploring its pathophysiology, management strategies, and the impact of comorbidities, reflecting an urgent need to address this complex condition.
Declining or Waning
- Traditional Risk Factor Studies:
Research focusing solely on traditional cardiovascular risk factors, such as hypertension and hyperlipidemia, has seen a decline as newer studies explore more complex interactions and novel risk factors. - Historical Perspectives on Cardiovascular Diseases:
Papers that provide historical overviews or retrospective analyses of cardiovascular disease management are less frequent, possibly overshadowed by contemporary and forward-looking research. - Single-Center Studies:
The prevalence of single-center studies appears to be waning as multicenter and collaborative research efforts gain traction, providing more robust and generalizable findings. - Basic Science Research:
There is a noticeable decrease in publications focused solely on basic science and laboratory studies, as the emphasis shifts towards translational research that bridges laboratory findings with clinical applications. - Non-Cardiovascular Comorbidity Research:
Research examining comorbidities that are not directly related to cardiovascular outcomes has diminished, with a stronger focus on the interplay between cardiovascular diseases and other systemic conditions.
Similar Journals
CANADIAN JOURNAL OF CARDIOLOGY
Empowering Cardiovascular Innovations Through Rigorous ResearchCanadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.
Journal of Cardiovascular Development and Disease
Fostering collaboration in the evolution of cardiac science.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.
Minerva Cardiology and Angiology
Advancing cardiovascular knowledge for a healthier tomorrow.Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.
Arquivos Brasileiros de Cardiologia
Pioneering open-access research in cardiovascular medicine.Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.
Journal of Cardiology
Advancing cardiovascular science for a healthier future.Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.
Vasa-European Journal of Vascular Medicine
Exploring the Frontiers of Vascular Medicine TogetherVasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.
Journal fur Kardiologie
Transforming Cardiology Through Rigorous Research.The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.
CARDIOLOGY CLINICS
Empowering clinicians with cutting-edge cardiology insights.CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.
AMERICAN JOURNAL OF CARDIOLOGY
Empowering Healthcare Professionals with Cutting-edge InsightsThe American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
Postepy w Kardiologii Interwencyjnej
Innovative research at the forefront of cardiovascular medicine.Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.